MedTrace Logo

A Multicenter Cancer Biospecimen Collection Study

NCT04510129 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1650

Last updated 2025-03-12

No results posted yet for this study

Summary

This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.

Conditions

Interventions

DIAGNOSTIC_TEST

OncoPrism™ assay

OncoPrism™ is a new approach to characterizing the immune component of pre-treatment tumor tissue.

Sponsors & Collaborators

  • Curebase Inc.

    collaborator INDUSTRY

  • Cofactor Genomics, Inc.

    lead INDUSTRY

Principal Investigators

  • Jarret Glasscock · Cofactor Genomics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04510129 on ClinicalTrials.gov